Treatment with rituximab in idiopathic membranous nephropathy

BACKGROUND: Rituximab represents a valid therapeutic option to induce remission in patients with primary glomerulonephritis. Despite several studies proving its efficacy in improving outcomes in patients with membranous nephropathy (MN), its role in therapeutic protocols is not yet defined. METHODS:...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Kidney J
Main Authors: Fiorentino, Marco, Tondolo, Francesco, Bruno, Francesca, Infante, Barbara, Grandaliano, Giuseppe, Gesualdo, Loreto, Manno, Carlo
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Glomerulopathies
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5162414/
https://ncbi.nlm.nih.gov/pubmed/27994855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfw091
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki